Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 22689091)

1.

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.

Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW.

Breast Cancer Res Treat. 2012 Jul;134(2):459-78. doi: 10.1007/s10549-012-2114-5. Epub 2012 Jun 12. Review.

2.

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.

Wigertz A, Ahlgren J, Holmqvist M, Fornander T, Adolfsson J, Lindman H, Bergkvist L, Lambe M.

Breast Cancer Res Treat. 2012 May;133(1):367-73. doi: 10.1007/s10549-012-1961-4.

PMID:
22286315
3.

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.

Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Gomez SL, Miles S, Neugut AI.

J Clin Oncol. 2010 Sep 20;28(27):4120-8. doi: 10.1200/JCO.2009.25.9655. Epub 2010 Jun 28.

4.

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.

Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK.

Breast Cancer Res Treat. 2011 Nov;130(2):681-9. doi: 10.1007/s10549-011-1703-z. Epub 2011 Aug 13.

PMID:
21842245
6.

Adherence to endocrine therapy for breast cancer.

Chlebowski RT, Geller ML.

Oncology. 2006;71(1-2):1-9. Epub 2007 Mar 5. Review.

PMID:
17344666
7.

Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

Eisen A, Trudeau M, Shelley W, Messersmith H, Pritchard KI.

Cancer Treat Rev. 2008 Apr;34(2):157-74. doi: 10.1016/j.ctrv.2007.11.001. Epub 2007 Dec 31. Review.

PMID:
18164821
8.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
9.

Adherence to long-term adjuvant hormonal therapy for breast cancer.

Gotay C, Dunn J.

Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):709-15. doi: 10.1586/erp.11.80. Review.

PMID:
22098287
11.

The influence of endocrine treatments for breast cancer on health-related quality of life.

Buijs C, de Vries EG, Mourits MJ, Willemse PH.

Cancer Treat Rev. 2008 Nov;34(7):640-55. doi: 10.1016/j.ctrv.2008.04.001. Epub 2008 Jun 2. Review.

PMID:
18514425
12.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

13.

Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.

Van Liew JR, Christensen AJ, de Moor JS.

J Cancer Surviv. 2014 Sep;8(3):521-31. doi: 10.1007/s11764-014-0374-2. Epub 2014 Jul 2. Review.

PMID:
24986227
14.

Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.

Amir E, Seruga B, Niraula S, Carlsson L, OcaƱa A.

J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309. doi: 10.1093/jnci/djr242. Epub 2011 Jul 9. Review.

15.
16.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
17.

[Aromatase inhibitors in the adjuvant therapy of breast cancer].

Bauerschlag D, Schem C, Maass N, Jonat W.

Gynakol Geburtshilfliche Rundsch. 2005 Jun;45(3):132-6. German.

PMID:
15990437
18.

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.

Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, Grann VR, Hershman DL.

J Clin Oncol. 2011 Jun 20;29(18):2534-42. doi: 10.1200/JCO.2010.33.3179. Epub 2011 May 23.

19.

Adherence rates and correlates in long-term hormonal therapy.

Dunn J, Gotay C.

Vitam Horm. 2013;93:353-75. doi: 10.1016/B978-0-12-416673-8.00003-4. Review.

PMID:
23810015
20.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. doi: 10.1002/14651858.CD004562.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.

PMID:
18843661
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk